Molecular Partners AG MOLN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12/08/22 EST
6.65UNCH (UNCH)
Volume
94
52 week range
5.50 - 32.04
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.66
  • 52 Week High32.04
  • 52 Week High Date01/14/22
  • 52 Week Low5.50
  • 52 Week Low Date09/06/22

Key Stats

  • Market Cap239.493M
  • Shares Out36.01M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-65.3

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.66
  • 52 Week High32.04
  • 52 Week High Date01/14/22
  • 52 Week Low5.50
  • 52 Week Low Date09/06/22
  • Market Cap239.493M
  • Shares Out36.01M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-65.3

RATIOS/PROFITABILITY

  • EPS (TTM)3.57
  • P/E (TTM)1.86
  • Fwd P/E (NTM)-
  • EBITDA (TTM)125.659M
  • ROE (TTM)62.46%
  • Revenue (TTM)200.625M
  • Gross Margin (TTM)-
  • Net Margin (TTM)62.20%
  • Debt To Equity (MRQ)2.05%

EVENTS

  • Earnings Date03/13/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Molecular Partners AG

 

Profile

MORE
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical...
William Burns
Non-Executive Independent Chairman of the Board
Patrick Amstutz Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Michael Stumpp Ph.D.
Chief Operating Officer, Member of the Management Board
Andreas Emmenegger
Chief Financial Officer, Member of the Management Board
Address
Wagistrasse 14
Schlieren
8952
Switzerland